Send mail to Author

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    ______   _    _      ___      ______     ___    
 /_   _//  /_   _// | \  / ||   / _ \\   /_   _//   / _ \\  
 `-| |,-    -| ||-  |  \/  ||  / //\ \\  `-| |,-   | / \ || 
   | ||     _| ||_  | .  . || |  ___  ||   | ||    | \_/ || 
   |_||    /_____// |_|\/|_|| |_||  |_||   |_||     \___//  
   `-`'    `-----`  `-`  `-`  `-`   `-`    `-`'     `---`   
                                                            
 


Back to frontdoor view